Global Kras Inhibitors Market GRÖSSEN- UND MARKTANTEILSANALYSE - WACHSTUMSTRENDS UND PROGNOSEN (2024 - 2031)

Global Kras Inhibitors Market wird segmentiert Durch Drogentyp (kleine Molekülinhibitoren, monoklonale Antikörper, Kombinationstherapien), Durch Indication (Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer, Pancreatic Cancer), By Route of Administration (Oral, Intravenous, Others), By Cancer Type (Lung Cancer, Pancreatic Cancer, Colorectal Cancers, Andere) Der Bericht bietet den Wert (in Mio. USD) für die genannten Segmente.

Global Kras Inhibitors Market Leaders

  • Amgen
  • Boehringer Ingelheim
  • Mirati Therapeuten
  • Novartis
  • BrückeBio Pharma
*Disclaimer: Major players are listed in no particular order.

Global Kras Inhibitors Market - Company List

  • Amgen
  • Boehringer Ingelheim
  • Mirati Therapeuten
  • Novartis
  • BrückeBio Pharma
  • Erasca
  • Innovent Biologics, Inc.
  • Incyte
  • Jemincare
  • Cardiff Onkologie, Inc.

Global Kras Inhibitors Market Report Snapshots

Buy Now